Found: 21
Select item for more details and to access through your institution.
The RUNX Family Defines Trk Phenotype and Aggressiveness of Human Neuroblastoma through Regulation of p53 and MYCN.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 4, p. 544, doi. 10.3390/cells12040544
- By:
- Publication type:
- Article
Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation.
- Published in:
- Genes to Cells, 2009, v. 14, n. 12, p. 1429, doi. 10.1111/j.1365-2443.2009.01359.x
- By:
- Publication type:
- Article
Plk3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation.
- Published in:
- Genes to Cells, 2009, v. 14, n. 7, p. 775, doi. 10.1111/j.1365-2443.2009.01309.x
- By:
- Publication type:
- Article
DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN -Amplified Neuroblastoma IMR32 Cells.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 9012, doi. 10.3390/ijms24109012
- By:
- Publication type:
- Article
Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 15, p. 3700, doi. 10.3390/ijms20153700
- By:
- Publication type:
- Article
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10772-y
- By:
- Publication type:
- Article
High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer.
- Published in:
- International Journal of Oncology, 2021, v. 58, n. 1, p. 57
- By:
- Publication type:
- Article
Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
- Published in:
- Oncogene, 2004, v. 23, n. 35, p. 5901, doi. 10.1038/sj.onc.1207782
- By:
- Publication type:
- Article
An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 10, p. 1448, doi. 10.1002/1878-0261.12110
- By:
- Publication type:
- Article
NFBD1/MDC1 Is Phosphorylated by PLK1 and Controls G2/M Transition through the Regulation of a TOPOIIα-Mediated Decatenation Checkpoint.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0082744
- By:
- Publication type:
- Article
Acceleration or Brakes: Which Is Rational for Cell Cycle-Targeting Neuroblastoma Therapy?
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 5, p. 750, doi. 10.3390/biom11050750
- By:
- Publication type:
- Article
CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/2752417
- By:
- Publication type:
- Article
A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 2, p. 337, doi. 10.1007/s00262-020-02686-6
- By:
- Publication type:
- Article
Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma.
- Published in:
- Oncogenesis, 2021, v. 10, n. 11, p. 1, doi. 10.1038/s41389-021-00363-6
- By:
- Publication type:
- Article
Editorial: Neuroblastoma: Signal Crosstalk and Future Insight Into Clinical Trials.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.861963
- By:
- Publication type:
- Article
High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0226707
- By:
- Publication type:
- Article
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma.
- Published in:
- Cancer Diagnosis & Prognosis, 2023, v. 3, n. 2, p. 230, doi. 10.21873/cdp.10206
- By:
- Publication type:
- Article
High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer.
- Published in:
- Oncology Reports, 2020, v. 44, n. 1, p. 252, doi. 10.3892/or.2020.7610
- By:
- Publication type:
- Article
Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
- Published in:
- International Journal of Cancer, 2008, v. 123, n. 9, p. 2087, doi. 10.1002/ijc.23776
- By:
- Publication type:
- Article
Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN.
- Published in:
- Cancer Science, 2022, v. 113, n. 12, p. 4193, doi. 10.1111/cas.15555
- By:
- Publication type:
- Article
FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis.
- Published in:
- Cancer Science, 2022, v. 113, n. 2, p. 587, doi. 10.1111/cas.15205
- By:
- Publication type:
- Article